Are you losing hair?
Do you have scalp problems?
About Duopharma Biotech
Duopharma Biotech Berhad Group, founded in 1978 as Duopharma (M) Sendirian Berhad and incorporated in 2000, is today one of Malaysia’s leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad. With expertise in Manufacturing, Research & Development, and Commercialisation & Marketing, the company offers a wide range of over 300 generic drugs, including well-known products like Crystorvas, Omesecand Prelica, as well as Consumer Healthcare (CHC) prominent products such as CHAMPS®, FLAVETTES®, PROVITON®, and Uphamol, enjoying popularity in Malaysia and beyond. Moreover, Duopharma has ventured into the biosimilars domain through strategic collaborations with reputable international partners, resulting in commercialised brands like ERYSAA®, Basalog One®, and Zuhera. Headquartered in Kuala Lumpur, Malaysia, the company operates three manufacturing plants in Klang, Bangi, and Glenmarie, Selangor, and has subsidiary companies in Indonesia, the Philippines, and Singapore, along with a representative office in Jakarta, Indonesia.
About SCM Lifescience
SCM Lifescience is a reasearch-based biopharmaceutical company focused on developing next-generation stem cell therapeutics for severe inflammatory immune disease. It has a robust pipeline in clinical and pre-clinical stages based on its proprietary platform technologies in isolation and manufacturing.
SCM Lifescience has intellectual property patents for its high-purity stem cell isolation technology and subfractionation culturing method, in major markets including Korea, US, Japan, China and the EU.
Our globally patented technology serves to provide patients with high-homogeneity, high-efficacy, and low-cost stem cell therapies.
Additionally, our research focuses on the field of regenerative medicine for technological breakthroughs including the regeneration of hair, skin, cartilage, bone and other various tissues. We are also developing cosmeceuticals for atopic dermatitis and alopecia patients.
